Jon E. Sprague

2.6k total citations
95 papers, 1.9k citations indexed

About

Jon E. Sprague is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Molecular Biology. According to data from OpenAlex, Jon E. Sprague has authored 95 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cellular and Molecular Neuroscience, 37 papers in Toxicology and 20 papers in Molecular Biology. Recurrent topics in Jon E. Sprague's work include Forensic Toxicology and Drug Analysis (37 papers), Neurotransmitter Receptor Influence on Behavior (33 papers) and Neuroscience and Neuropharmacology Research (18 papers). Jon E. Sprague is often cited by papers focused on Forensic Toxicology and Drug Analysis (37 papers), Neurotransmitter Receptor Influence on Behavior (33 papers) and Neuroscience and Neuropharmacology Research (18 papers). Jon E. Sprague collaborates with scholars based in United States, Italy and Canada. Jon E. Sprague's co-authors include David E. Nichols, Edward Mills, Daniel E. Rusyniak, Matthew L. Banks, Travis J. Worst, Toren Finkel, David F. Kisor, Kevin Haynes, Gregory G. Grecco and Paul W. Czoty and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and The Journal of Physiology.

In The Last Decade

Jon E. Sprague

91 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon E. Sprague United States 25 928 816 577 440 351 95 1.9k
William Lee Hearn United States 29 798 0.9× 1.1k 1.3× 499 0.9× 338 0.8× 597 1.7× 47 2.4k
Gantt P. Galloway United States 34 632 0.7× 1.6k 1.9× 711 1.2× 656 1.5× 303 0.9× 77 3.7k
Hans Sachs Germany 30 888 1.0× 404 0.5× 209 0.4× 321 0.7× 330 0.9× 76 2.2k
Nassima Ait‐Daoud United States 31 382 0.4× 1.8k 2.2× 490 0.8× 813 1.8× 611 1.7× 85 3.7k
Justin L. Poklis United States 37 1.2k 1.3× 1.3k 1.6× 763 1.3× 1.4k 3.2× 840 2.4× 144 3.8k
Tibor M. Brunt Netherlands 27 1.1k 1.2× 593 0.7× 769 1.3× 707 1.6× 198 0.6× 62 2.2k
Gerhard A. Wiesbeck Switzerland 34 258 0.3× 776 1.0× 591 1.0× 423 1.0× 371 1.1× 127 3.4k
Paolo Nencini Italy 25 322 0.3× 865 1.1× 288 0.5× 183 0.4× 291 0.8× 98 1.6k
Shih‐Ku Lin Taiwan 31 215 0.2× 728 0.9× 420 0.7× 550 1.3× 413 1.2× 126 3.0k
Kirsten C. Morley Australia 28 340 0.4× 851 1.0× 607 1.1× 437 1.0× 164 0.5× 107 2.5k

Countries citing papers authored by Jon E. Sprague

Since Specialization
Citations

This map shows the geographic impact of Jon E. Sprague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon E. Sprague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon E. Sprague more than expected).

Fields of papers citing papers by Jon E. Sprague

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon E. Sprague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon E. Sprague. The network helps show where Jon E. Sprague may publish in the future.

Co-authorship network of co-authors of Jon E. Sprague

This figure shows the co-authorship network connecting the top 25 collaborators of Jon E. Sprague. A scholar is included among the top collaborators of Jon E. Sprague based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon E. Sprague. Jon E. Sprague is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sprague, Jon E., et al.. (2025). Non-fatal opioid overdose associated predominantly with the benzimidazolone, cychlorphine. Clinical Toxicology. 64(2). 146–147.
2.
Sprague, Jon E., et al.. (2025). Enhanced pharmacokinetic and pharmacodynamic effects of combining p-fluorofentanyl and fentanyl. Drug and Alcohol Dependence. 272. 112710–112710. 2 indexed citations
3.
Freiermuth, Caroline E., Jennifer L. Brown, Michael S. Lyons, et al.. (2024). State program enables the identification of factors associated with naloxone awareness, self-efficacy, and use for overdose reversal: A cross-sectional, observational study in an urban emergency department population. Journal of Substance Use and Addiction Treatment. 167. 209506–209506. 2 indexed citations
4.
Banks, Matthew L. & Jon E. Sprague. (2024). The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder. Addiction Biology. 29(2). e13369–e13369. 4 indexed citations
5.
Lambert, Joshua, Caroline E. Freiermuth, Jennifer L. Brown, et al.. (2024). Association of genetic variants in CYP3A5, DRD2 and NK1R with opioid overdose. Chemico-Biological Interactions. 403. 111242–111242. 1 indexed citations
6.
Sprague, Jon E., Caroline E. Freiermuth, Joshua Lambert, et al.. (2024). Opioid use disorder risk alleles in self-reported assigned African American/Afro-Caribbean and European biogeographical genetic ancestry groups and in males and females. The Pharmacogenomics Journal. 24(4). 23–23. 3 indexed citations
7.
Sprague, Jon E., et al.. (2024). In vivo pharmacokinetic, pharmacodynamic and brain concentration comparison of fentanyl and para-fluorofentanyl in rats. Archives of Toxicology. 99(1). 287–297. 5 indexed citations
8.
Punches, Brittany E., Caroline E. Freiermuth, Jon E. Sprague, et al.. (2024). Screening for problematic opioid use in the emergency department: Comparison of two screening measures. SHILAP Revista de lepidopterología. 5(1). e13106–e13106. 2 indexed citations
9.
Freiermuth, Caroline E., David F. Kisor, Joshua Lambert, et al.. (2023). Genetic Variants Associated With Opioid Use Disorder. Clinical Pharmacology & Therapeutics. 113(5). 1089–1095. 5 indexed citations
10.
Sprague, Jon E., et al.. (2022). COVID-19 economic impact payments and opioid overdose deaths. International Journal of Drug Policy. 102. 103608–103608. 9 indexed citations
11.
Sprague, Jon E., Christopher L. Riley, & Edward Mills. (2018). Body temperature regulation and drugs of abuse. Handbook of clinical neurology. 157. 623–633. 9 indexed citations
12.
Yadav, Rajeev, et al.. (2017). Raman Spectroscopic Signature Markers of Dopamine–Human Dopamine Transporter Interaction in Living Cells. ACS Chemical Neuroscience. 8(7). 1510–1518. 30 indexed citations
13.
Grecco, Gregory G., et al.. (2016). Cooling down the bath salts: Carvedilol attenuation of methylone and mephedrone mediated hyperthermia. Toxicology Letters. 263. 11–15. 8 indexed citations
14.
Banks, Matthew L., Travis J. Worst, Daniel E. Rusyniak, & Jon E. Sprague. (2014). Synthetic Cathinones (“Bath Salts”). Journal of Emergency Medicine. 46(5). 632–642. 86 indexed citations
15.
Banks, Matthew L., Jon E. Sprague, David F. Kisor, et al.. (2007). Ambient Temperature Effects on 3,4-Methylenedioxymethamphetamine-Induced Thermodysregulation and Pharmacokinetics in Male Monkeys. Drug Metabolism and Disposition. 35(10). 1840–1845. 37 indexed citations
16.
Sprague, Jon E., et al.. (2005). Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model*. Critical Care Medicine. 33(6). 1311–1316. 57 indexed citations
17.
Sprague, Jon E.. (2001). Teaching Cardiac Arrhythmias: A Focus on Pathophysiology and Pharmacology. American Journal of Pharmaceutical Education. 65(2). 169–177. 1 indexed citations
18.
Sprague, Jon E., et al.. (2001). In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol. Synapse. 43(2). 118–121. 35 indexed citations
19.
Sprague, Jon E., et al.. (2000). Development and Implementation of an Integrated Cardiovascular Module in a PharmD Curriculum. American Journal of Pharmaceutical Education. 64(1). 20–26. 6 indexed citations
20.
Marona‐Lewicka, Danuta, Gyu‐Seek Rhee, Jon E. Sprague, & David E. Nichols. (1995). Psychostimulant-like effects of p-fluoroamphetamine in the rat. European Journal of Pharmacology. 287(2). 105–113. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Lee Hearn Breakdown of academic impact, for papers by Gantt P. Galloway Breakdown of academic impact, for papers by Hans Sachs Breakdown of academic impact, for papers by Nassima Ait‐Daoud Breakdown of academic impact, for papers by Justin L. Poklis Breakdown of academic impact, for papers by Tibor M. Brunt Breakdown of academic impact, for papers by Gerhard A. Wiesbeck Breakdown of academic impact, for papers by Paolo Nencini Breakdown of academic impact, for papers by Shih‐Ku Lin Breakdown of academic impact, for papers by Kirsten C. Morley
Rankless by CCL
2026